BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10802937)

  • 1. Promoter-region hypermethylation and gene silencing in human cancer.
    Herman JG; Baylin SB
    Curr Top Microbiol Immunol; 2000; 249():35-54. PubMed ID: 10802937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of DNA methylation in hematologic malignancies.
    Rush LJ; Plass C
    Cancer Lett; 2002 Nov; 185(1):1-12. PubMed ID: 12142073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer.
    Yang Q; Nakamura M; Nakamura Y; Yoshimura G; Suzuma T; Umemura T; Shimizu Y; Mori I; Sakurai T; Kakudo K
    Clin Cancer Res; 2002 Sep; 8(9):2890-3. PubMed ID: 12231533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA hypermethylation: when tumour suppressor genes go silent.
    Garinis GA; Patrinos GP; Spanakis NE; Menounos PG
    Hum Genet; 2002 Aug; 111(2):115-27. PubMed ID: 12189484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Promoter hypermethylation and CpG island methylator phenotype in colorectal carcinogenesis].
    Matsubara N
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1659-64. PubMed ID: 20841928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of DNA hypermethylation in human neoplasia.
    Toyota M; Issa JP
    Electrophoresis; 2000 Jan; 21(2):329-33. PubMed ID: 10675010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
    Esteller M
    Oncogene; 2002 Aug; 21(35):5427-40. PubMed ID: 12154405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
    Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
    J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of promoter region of LATS1--a CDK interacting protein in oral squamous cell carcinomas--a pilot study in India.
    Reddy VR; Annamalai T; Narayanan V; Ramanathan A
    Asian Pac J Cancer Prev; 2015; 16(4):1599-603. PubMed ID: 25743838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation of tumor suppressor genes in cancer.
    Herman JG
    Semin Cancer Biol; 1999 Oct; 9(5):359-67. PubMed ID: 10547344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cancer epigenetics].
    Chang DK
    Korean J Gastroenterol; 2004 Jul; 44(1):1-12. PubMed ID: 15266127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MPP3 inactivation by promoter CpG islands hypermethylation in colorectal carcinogenesis.
    Feng X; Chen K; Ye S; Wang H; Wei G; Tan W; Cheng S; Zhang Y; Liu S; Zhou Y
    Cancer Biomark; 2012; 11(2-3):99-106. PubMed ID: 23011156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.
    Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Williams NN; Kaiser LR; Croce CM
    Cancer Res; 2003 Jun; 63(12):3352-5. PubMed ID: 12810670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5'-CpG island promoter hypermethylation of the CAV-1 gene in breast cancer patients of Kashmir.
    Syeed N; Hussain F; Husain SA; Siddiqi MA
    Asian Pac J Cancer Prev; 2012; 13(1):371-5. PubMed ID: 22502704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dormant hypermethylated tumour suppressor genes: questions and answers.
    Esteller M
    J Pathol; 2005 Jan; 205(2):172-80. PubMed ID: 15643671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer.
    Lujambio A; Portela A; Liz J; Melo SA; Rossi S; Spizzo R; Croce CM; Calin GA; Esteller M
    Oncogene; 2010 Dec; 29(48):6390-401. PubMed ID: 20802525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA Methylation in Colorectal Cancer.
    Kaur S; Lotsari-Salomaa JE; Seppänen-Kaijansinkko R; Peltomäki P
    Adv Exp Med Biol; 2016; 937():109-22. PubMed ID: 27573897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifaceted Roles of DNA Methylation in Neoplastic Transformation, from Tumor Suppressors to EMT and Metastasis.
    Casalino L; Verde P
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32806509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma.
    Alaminos M; Davalos V; Cheung NK; Gerald WL; Esteller M
    J Natl Cancer Inst; 2004 Aug; 96(16):1208-19. PubMed ID: 15316056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.